HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hisashi Matsumoto Selected Research

Hemoperfusion

1/2017Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
10/2010Selection of acute blood purification therapy according to severity score and blood lactic acid value in patients with septic shock.
1/2010Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients.
7/2008Relationship between treatment resistance to hemoperfusion using a polymyxin B-immobilized fiber column and oxidative stress.
1/2008Effectiveness of continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter after polymyxin B-immobilized fiber column therapy of septic shock.
9/2007Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
5/2007Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
11/2006Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: report of a case.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hisashi Matsumoto Research Topics

Disease

7Septic Shock (Toxic Shock Syndrome)
01/2017 - 11/2006
7Wounds and Injuries (Trauma)
05/2015 - 07/2002
3Sepsis (Septicemia)
01/2017 - 05/2010
3Critical Illness (Critically Ill)
10/2010 - 01/2008
2Venous Thrombosis (Deep-Vein Thrombosis)
06/2010 - 01/2009
2Lung Injury
05/2010 - 07/2008
2Endotoxemia
01/2010 - 05/2007
2Heart Arrest (Cardiac Arrest)
11/2009 - 07/2002
1Respiratory Insufficiency (Respiratory Failure)
11/2021
1Traumatic Brain Injuries (Traumatic Brain Injury)
09/2021
1Knee Injuries (Knee Injury)
03/2021
1Osteoarthritis
03/2021
1Knee Osteoarthritis
03/2021
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Infections
01/2017
1Bone Fractures (Bone Fracture)
01/2017
1Atrophic Muscular Disorders
01/2016
1Ischemia
05/2015
1Ventricular Fibrillation
08/2010
1Thrombosis (Thrombus)
06/2010
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
06/2010
1Heart Diseases (Heart Disease)
05/2010
1Pulmonary Edema
05/2010
1Pulmonary Hypertension
05/2010
1Hypoxia (Hypoxemia)
05/2010
1Myoma
01/2009
1Rib Fractures (Rib Fracture)
12/2008
1Neoplasms (Cancer)
09/2008
1Carcinoma (Carcinomatosis)
09/2008
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2008
1Acute Lung Injury
07/2008
1Myocardial Infarction
01/2006
1Xanthogranulomatous cholecystitis
09/2003
1Gallbladder Neoplasms (Gallbladder Cancer)
09/2003
1Hemorrhage
11/2002
1Esophageal and Gastric Varices (Esophageal Varices)
11/2002
1Thoracic Injuries (Chest Injury)
07/2002
1Shock
07/2002

Drug/Important Bio-Agent (IBA)

8Polymyxin B (Aerosporin)FDA LinkGeneric
01/2017 - 11/2006
2Proteins (Proteins, Gene)FDA Link
01/2017 - 05/2007
2EndotoxinsIBA
01/2017 - 05/2007
2Tumor Biomarkers (Tumor Markers)IBA
09/2008 - 09/2003
1PotassiumIBA
09/2021
1Glucose (Dextrose)FDA LinkGeneric
09/2021
1Transforming Growth Factor beta (TGF-beta)IBA
01/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017
1Lactic Acid (Lactate)FDA LinkGeneric
10/2010
1Leukocyte Elastase (Neutrophil Elastase)IBA
06/2010
1Atrial Natriuretic Factor (ANF)IBA
05/2010
1F2-Isoprostanes (F2 Isoprostanes)IBA
07/2008
1Polymethyl Methacrylate (Sol)IBA
01/2008
1Plasminogen Activator Inhibitor 1IBA
09/2007
1CyanoacrylatesIBA
11/2002

Therapy/Procedure

8Hemoperfusion
01/2017 - 11/2006
5Therapeutics
01/2017 - 05/2007
2Resuscitation
05/2015 - 02/2010
2Thrombectomy
06/2010 - 01/2009
2Thoracotomy
11/2009 - 07/2002
2Pancreaticoduodenectomy
09/2008 - 09/2003
1Artificial Respiration (Mechanical Ventilation)
11/2021
1Activities of Daily Living (ADL)
03/2021
1Glycemic Control
01/2019
1Length of Stay
01/2016
1Surgical Amputation (Amputations)
05/2015
1Critical Care (Surgical Intensive Care)
01/2014
1Continuous Renal Replacement Therapy
10/2010
1Defibrillators (Defibrillator)
08/2010
1Hysterectomy
01/2009
1Stents
12/2008
1X-Ray Film
12/2008
1Adjuvant Chemotherapy
09/2008
1Hemodiafiltration
01/2008
1Time-to-Treatment
01/2006
1Catheters
07/2002
1Pneumonectomy (Lung Volume Reduction)
07/2002
1Surgical Instruments (Clip)
07/2002
1Ligation
07/2002